The McLeod Cancer Research Department has made national state-of-the-art cancer research trials for the prevention and treatment of cancer available to eligible patients in the northeastern region of South Carolina for more than 30 years.
McLeod's participation in cancer research is supported through its association with the Southeast Clinical Oncology Research Consortium (SCOR), a group of community hospitals in North Carolina, South Carolina, Georgia, Virginia and Tennessee. For a list of clinical trials we offer through SCOR, click here.
McLeod also collaborates in research with national cancer alliances and research centers including those listed below as well as pharmaceuticals:
- National Cancer Institute (NCI)
- Southwest Oncology Group
- Sun Coast Community Clinical Oncology Program
- Cancer Trials Support Unit
- The Alliance for Clinical Trials in Oncology (American College of Surgeons Oncology Group, Cancer and Leukemia Group B, and North Central Cancer Treatment Group)
- NRG which consists of the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)
- Comprehensive Cancer Center of Wake Forest University
- The University of Rochester Cancer Center
Patients and physicians who participate in cancer research through McLeod also have access to three clinical research professionals who offer guidance and support. Jo Capostosti, RN, BSN, CCRP; Dorie Sturgill, RN; and Martha Adams, RN, MSN, OCN, CCRP; are responsible for coordinating the research protocols for McLeod.
Oncology is one of the largest areas of research at McLeod. Currently, the department has more than 100 patients involved in cancer studies and betweent 20 to 25 protocols open that patients can be enrolled in. Areas of cancer clinical research currently available at McLeod include: Brain Cancer, Breast Cancer, Head & Neck Cancer, Leukemia, Pancreatic Cancer, Prostate Cancer, Sarcoma, Small or Non-Small Cell Lung Cancer and Smoking Cessation.